Insider Trading Alert - SM, CERN, ITMN, CBI And AIRM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 4, 2013, 189 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $160.56 to $35,901,027,172.20.

Highlighted Stocks Traded by Insiders:

SM Energy (SM) - FREE Research Report

Quintana Julio M who is Director at SM Energy sold 3,218 shares at $88.64 on Dec. 4, 2013. Following this transaction, the Director owned 15,384 shares meaning that the stake was reduced by 17.3% with the 3,218-share transaction.

Lutey Mary Ellen who is VP & Regional Manager at SM Energy sold 7,294 shares at $90.64 on Dec. 4, 2013. Following this transaction, the VP & Regional Manager owned 45,358 shares meaning that the stake was reduced by 13.85% with the 7,294-share transaction.

The shares most recently traded at $90.50, down $0.14, or 0.16% since the insider transaction. Historical insider transactions for SM Energy go as follows:

  • 4-Week # shares sold: 37,961
  • 12-Week # shares sold: 44,493
  • 24-Week # shares sold: 59,593

The average volume for SM Energy has been 907,900 shares per day over the past 30 days. SM Energy has a market cap of $6.1 billion and is part of the basic materials sector and energy industry. Shares are up 75.23% year-to-date as of the close of trading on Wednesday.

SM Energy Company, an independent energy company, together with its subsidiaries, engages in the acquisition, exploration, exploitation, development, and production of crude oil, natural gas, and natural gas liquids in North America. The stock currently has a dividend yield of 0.11%. The company has a P/E ratio of 65.4. Currently there are 14 analysts that rate SM Energy a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SM - FREE

TheStreet Quant Ratings rates SM Energy as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, good cash flow from operations, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full SM Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cerner Corporation (CERN) - FREE Research Report

Patterson Neal L who is Chairman and CEO at Cerner Corporation sold 10,000 shares at $57.80 on Dec. 4, 2013. Following this transaction, the Chairman and CEO owned 2.9 million shares meaning that the stake was reduced by 0.34% with the 10,000-share transaction.

The shares most recently traded at $56.26, down $1.54, or 2.74% since the insider transaction. Historical insider transactions for Cerner Corporation go as follows:

  • 4-Week # shares sold: 8,700
  • 12-Week # shares sold: 8,700
  • 24-Week # shares sold: 8,700

The average volume for Cerner Corporation has been 1.4 million shares per day over the past 30 days. Cerner Corporation has a market cap of $19.7 billion and is part of the technology sector and computer software & services industry. Shares are up 48.24% year-to-date as of the close of trading on Wednesday.

Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers worldwide. The company has a P/E ratio of 44.9. Currently there are 9 analysts that rate Cerner Corporation a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CERN - FREE

TheStreet Quant Ratings rates Cerner Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Cerner Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

InterMune (ITMN) - FREE Research Report

Welch Daniel G who is Chairman, CEO and President at InterMune sold 20,000 shares at $13.99 on Dec. 4, 2013. Following this transaction, the Chairman, CEO and President owned 137,434 shares meaning that the stake was reduced by 12.7% with the 20,000-share transaction.

The shares most recently traded at $13.85, down $0.14, or 1.01% since the insider transaction. Historical insider transactions for InterMune go as follows:

  • 12-Week # shares sold: 20,000
  • 24-Week # shares sold: 30,002

The average volume for InterMune has been 1.1 million shares per day over the past 30 days. InterMune has a market cap of $1.2 billion and is part of the health care sector and drugs industry. Shares are up 43.14% year-to-date as of the close of trading on Wednesday.

InterMune, Inc., a biotechnology company, engages in the research, development, and commercialization of therapies in pulmonology and orphan fibrotic diseases. The company focuses on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. Currently there are 9 analysts that rate InterMune a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ITMN - FREE

TheStreet Quant Ratings rates InterMune as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and generally high debt management risk. Get the full InterMune Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Chicago Bridge & Iron Company (CBI) - FREE Research Report

Asherman Philip K who is President and CEO at Chicago Bridge & Iron Company sold 75,000 shares at $76.81 on Dec. 4, 2013. Following this transaction, the President and CEO owned 460,518 shares meaning that the stake was reduced by 14.01% with the 75,000-share transaction.

The shares most recently traded at $76.08, down $0.73, or 0.96% since the insider transaction. Historical insider transactions for Chicago Bridge & Iron Company go as follows:

  • 4-Week # shares sold: 38,340
  • 12-Week # shares sold: 125,982
  • 24-Week # shares sold: 246,191

The average volume for Chicago Bridge & Iron Company has been 1.1 million shares per day over the past 30 days. Chicago Bridge & Iron Company has a market cap of $8.1 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 62.48% year-to-date as of the close of trading on Wednesday.

Chicago Bridge & Iron Company N.V., an energy infrastructure focused company, provides conceptual design, technology, engineering, procurement, fabrication, construction, and commissioning services to customers in the energy, petrochemical, and natural resource industries worldwide. The stock currently has a dividend yield of 0.27%. The company has a P/E ratio of 22.7. Currently there are 10 analysts that rate Chicago Bridge & Iron Company a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CBI - FREE

TheStreet Quant Ratings rates Chicago Bridge & Iron Company as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Chicago Bridge & Iron Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Air Methods (AIRM) - FREE Research Report

Todd Aaron D who is Ceo at Air Methods sold 5,000 shares at $56.31 on Dec. 4, 2013. Following this transaction, the Ceo owned 82,371 shares meaning that the stake was reduced by 5.72% with the 5,000-share transaction.

The shares most recently traded at $55.23, down $1.08, or 1.96% since the insider transaction. Historical insider transactions for Air Methods go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 262,500

The average volume for Air Methods has been 339,800 shares per day over the past 30 days. Air Methods has a market cap of $2.2 billion and is part of the health care sector and health services industry. Shares are up 50.34% year-to-date as of the close of trading on Wednesday.

Air Methods Corporation, together with its subsidiaries, provides air medical emergency transport services and systems in the United States. The company operates in two segments, Air Medical Services (AMS) and United Rotorcraft (UR). The company has a P/E ratio of 30.8. Currently there are 5 analysts that rate Air Methods a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AIRM - FREE

TheStreet Quant Ratings rates Air Methods as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Air Methods Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

These 10 Stocks Are Helping Drive the Market Rally Monday

These 10 Stocks Are Helping Drive the Market Rally Monday

Oil Prices Are Having a Terrible Week, and Next Week May Not Be Any Better

Oil Prices Are Having a Terrible Week, and Next Week May Not Be Any Better

Live From NAPE: Oil and Gas Drillers Excited About $60 Oil

Live From NAPE: Oil and Gas Drillers Excited About $60 Oil

What $70 Oil Means to M&A Market

What $70 Oil Means to M&A Market

10 Energy Stocks You Must Buy With Oil Prices Rallying

10 Energy Stocks You Must Buy With Oil Prices Rallying